Haegele K D, McLean A J, du Souich P, Barron K, Laquer J, McNay J L, Carrier O
Br J Clin Pharmacol. 1978 Jun;5(6):489-94. doi: 10.1111/j.1365-2125.1978.tb01662.x.
1 Serum and urine from hypertensive subjects on chronic oral hydrallazine therapy were studied using gas chromatographic/mass spectrometry techniques. 2 Metabolites resulting from acetylation, hydrolysis and conjugation reactions were detected. The acetone, pyruvate and alpha-ketoglutarate hydrazone were identified. 3 The activity of the pyruvate and alpha-ketoglutarate hydrazones were compared with that of hydrallazine using isolated rabbit aortic strips. 4 Both hydrazones were active under in vitro conditions, producing smooth muscle relaxant effects equal to those of hydrallazine. 5 It is concluded that hydrazone metabolites will contribute to the hypotensive effects of hydrallazine therapy in proportion to their relative abundance, persistence in vascular tissues and intrinsic activity.
1 使用气相色谱/质谱技术研究了接受慢性口服肼苯哒嗪治疗的高血压患者的血清和尿液。2 检测到了由乙酰化、水解和结合反应产生的代谢产物。鉴定出了丙酮、丙酮酸和α-酮戊二酸腙。3 使用离体兔主动脉条比较了丙酮酸和α-酮戊二酸腙与肼苯哒嗪的活性。4 两种腙在体外条件下均有活性,产生的平滑肌松弛作用与肼苯哒嗪相当。5 得出的结论是,腙代谢产物将根据其相对丰度、在血管组织中的持久性和内在活性对肼苯哒嗪治疗的降压作用产生影响。